Clinical Trials · NCT07589686
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Hoffmann-La Roche
- Enrollment
- 486
- Start date
- Jun 2026
- Locations
- See registry
- Primary endpoint
- Percentage Change in Body Weight between Arms 1 and 6